Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rashmi Mishra has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Sebastian John

    Brain and Cerebrovascular Mechanobiology Research, Laboratory of Translational Mechanobiology, Department of Neurobiology Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram Kerala India

    6 shared publications
  • Aswani P. Krishna

    Brain and Cerebrovascular Mechanobiology Research, Laboratory of Translational Mechanobiology, Department of Neurobiology Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram Kerala India

    2 shared publications
  • Gayathri K. G.

    Laboratory of Translational Mechanobiology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India

    2 shared publications
  • Krishnankutty Chandrika Sivakumar

    Distributed Information Sub-Centre, BRIC–Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud PO, Poojappura, Thiruvananthapuram 695014, Kerala, India

    2 shared publications
  • Puja Laxmanrao Shinde

    Translational Mechanobiology Laboratory, BRIC-Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud PO, Poojappura, Thiruvananthapuram-695014, India

    2 shared publications
  • Puja Laxmanrao Shinde

    Translational Mechanobiology Laboratory, BRIC–Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud PO, Poojappura, Thiruvananthapuram 695014, Kerala, India

    2 shared publications

Latest Publications

  • Open Access

    Amalaki Rasayana, a Gallic Acid-Enriched Traditional Phytomedicine, Attenuates Left Ventricular Cardiac Remodeling Associated with Excess Extracellular Galectin-3 Through Modulation of Surface Engagement and Compartmentalization: A Non-Canonical Mechanism of Antioxidant Cardioprotection

    by Puja Laxmanrao Shinde, Siddhartha Singh, Vikas Kumar, K. C. Sivakumar, Amit Mishra, Rashmi Mishra

    Natural polyphenol-rich interventions are widely investigated for antioxidant protection, yet whether such interventions influence non-redox mechanisms of cardiac mechanoadaptation remains incompletely understood. Amalaki Rasayana (AR) is a traditional phytomedicine with antioxidant properties used for cardioprotection. Here, we investigated whether extracellular C-terminal-epitope-reactive Galectin-3 (Gal-3) species are associated with altered cardiomyocyte surface organization and mechanotransduction-associated signaling, and whether these responses are modulated by AR. In complementary mechanistic cardiomyocyte cell-culture experiments, we further examined whether gallic acid (GA), an analytically prominent and bioavailable constituent of AR, recapitulates selected AR-associated anti-hypertrophic effects. Using biologically aged and left ventricular pressure-overload rat models, followed by complementary in vitro cardiomyocyte mechanical-loading assays, biochemical and imaging approaches, and exploratory analyses of human serum and myocardial tissue, we examined epitope-resolved Gal-3 species, their compartmental distribution and surface-associated clustering, and associated mechanotransduction responses. Pressure overload increased extracellular and surface-associated C-terminal-epitope-reactive Gal-3 species, including a higher-molecular-weight population distinct from full-length Gal-3, accompanied by reduced intracellular Gal-3 and hypertrophic remodeling. C-terminal-epitope-enriched human serum induced surface-associated Gal-3 clustering and altered calcium responses, RhoA–ROCK1-F-actin organization, the NFATC2–MEF2A hypertrophic transcriptional axis, and nuclear stress responses. AR attenuated hypertrophic remodeling while shifting Gal-3 distribution away from extracellular and surface-associated C-terminal-epitope-reactive species toward intracellular retention. In complementary mechanical-loading experiments, GA recapitulated selected AR-associated effects. Additional mechanistic experiments supported roles for Gal-3 C-terminal-epitope (carbohydrate-recognition domain, CRD)-dependent surface engagement and Ser6-phosphorylation-sensitive regulation of intracellular Gal-3. Together, these findings support a potentially non-canonical, Gal-3-centered mechanism through which a polyphenol-rich antioxidant intervention may modulate pathological cardiac mechanoadaptation by regulating Gal-3 compartmentalization and surface engagement.

  • Open Access

    Galectin-3 C-epitope, ANP, PPIA, and albumin function as drug-responsive panel biomarkers and therapeutic targets in aging and pressure overload-induced cardiac hypertrophy

    by Puja Laxmanrao Shinde, Vikas Kumar, Siddhartha Singh, K.C. Sivakumar, Rashmi Mishra

    Biological aging (BA) and pressure overload-induced cardiac hypertrophy (PO-CH) are marked by myocardial thickening, fibrosis, and functional decline, culminating in an increased risk of heart failure. Effective clinical management requires biomarkers that not only track disease progression but also monitor therapeutic response. Using Amalaki Rasayana (AR), a cardioprotective nutraceutical-based medicine, in rat models of BA and PO-CH, we identified a panel of serum biomarkers whose treatment-induced decline was associated with disease regression. Among them, galectin-3 emerged in both full-length and oligomeric C-epitope cleaved forms, with the latter closely linked to pathological surface remodeling. Treatment with AR and its bioactive component gallic acid (GA) suppressed extracellular galectin-3 C-epitope oligomer accumulation by inhibiting full-length galectin-3 secretion through phosphorylation-dependent mechanisms and promotion of intracellular retention. Concurrently, serum levels of atrial natriuretic peptide (ANP), cyclophilin A (PPIA), and albumin (ALB) were consistently modulated by therapy. Validation in sera from elderly individuals and cardiac hypertrophy patients responding to conventional treatments supported the translational relevance of this biomarker panel. These findings establish a novel, mechanistically grounded biomarker set—galectin-3 C-epitope, ANP, PPIA, and ALB—for monitoring therapeutic response in cardiac hypertrophy, and position AR as a promising medicinal intervention against age- and pressure-induced cardiac pathology. GRAPHICAL HIGHLIGHTS: Galectin-3 C-epitope, ANP, PPIA, and ALB are elevated in aging and pressure overload driven left ventricular hypertrophy. Amalaki rasayana (AR) and Gallic Acid (GA) reduce these markers in cardiac tissue and circulation. AR and GA inhibit galectin-3 secretion and oligomeric binding to cardiomyocyte surfaces. AR and GA regulation predominantly occurs via phosphorylation-dependent cytoplasmic retention of galectin-3. These markers serve as potential therapeutic targets and diagnostic biomarkers.

  • Open Access

    Sustainable Rice Plant Growth Promotion by Bacteria Isolated from Rhizosphere Soil

    by Bikash Behera, Kumudini Mahto, Saikh Md Awesh Azam, Rashmi Ranjan Mishra, Bijay Kumar Sethi, Biswaranjan Pradhan, Santosh Kumar Singh, Tapaswini Hota, Harishankar Dey

    Jordan Journal of Agricultural Sciences Deanship of Scientific Research at The University of Jordan


  • Open Access

    Understanding the Combined Effects of High Glucose Induced Hyper-Osmotic Stress and Oxygen Tension in the Progression of Tumourigenesis: From Mechanism to Anti-Cancer Therapeutics

    by Gayathri K. G., Puja Laxmanrao Shinde, Sebastian John, Sivakumar K. C., Rashmi Mishra

    High glucose (HG), a hallmark of the tumour microenvironment, is also a biomechanical stressor, as it exerts hyper-osmotic stress (HG-HO), but not much is known regarding how tumour cells mechanoadapt to HG-HO. Therefore, this study aimed to delineate the novel molecular mechanisms by which tumour cells mechanoadapt to HG/HG-HO and whether phytochemical-based interference in these mechanisms can generate tumour-cell-selective vulnerability to cell death. Mannitol and L-glucose were used as hyper-osmotic equivalents of high glucose. The results revealed that the tumour cells can efficiently mechanoadapt to HG-HO only in the normoxic microenvironment. Under normoxic HG/HG-HO stress, tumour cells polySUMOylate a higher pool of mitotic driver pH3(Ser10), which translocates to the nucleus and promotes faster cell divisions. On the contrary, acute hypoxia dampens HG/HG-HO-associated excessive proliferation by upregulating sentrin protease SENP7. SENP7 promotes abnormal SUMOylation of pH3(Ser10), thereby restricting its nuclear entry and promoting the M-phase arrest and cell loss. However, the hypoxia-arrested cells that managed to survive showed relapse upon reversal to normoxia as well as upregulation of pro-survival-associated SENP1, and players in tumour growth signalling, autophagy, glycolytic pathways etc. Depletion of SENP1 in both normoxia and hypoxia caused significant loss of tumour cells vs undepleted controls. SENP1 was ascertained to restrict the abnormal SUMOylation of pH3(Ser10) in both normoxia and hypoxia, although not so efficiently in hypoxia, due to the opposing activity of SENP7. Co-treatment with Momordin Ic (MC), a natural SENP1 inhibitor, and Gallic Acid (GA), an inhibitor of identified major pro-tumourigenic signalling (both enriched in Momordica charantia), eliminated surviving tumour cells in normal glucose, HG and HG-HO normoxic and hypoxic microenvironments, suggesting that appropriate and enhanced polySUMOylation of pH3(Ser10) in response to HG/HG-HO stress was attenuated by this treatment along with further dampening of other key tumourigenic signalling, due to which tumour cells could no longer proliferate and grow.


  • Open Access

    Neurotherapeutic implications of sense and respond strategies generated by astrocytes and astrocytic tumours to combat pH mechanical stress

    by Sebastian John, Gayathri K. G., Aswani P. Krishna, Rashmi Mishra

    Aims: Astrocytes adapt to acute acid stress. Intriguingly, cancer cells with astrocytic differentiation thrive even better in an acidic microenvironment. How changes in extracellular pH (pHe) are sensed and measured by the cell surface assemblies that first intercept the acid stress, and how this information is relayed downstream for an appropriate survival response remains largely uncharacterized.Methods: In vitro cell‐based studies were combined with an in vivo animal model to delineate the machinery involved in pH microenvironment sensing and generation of mechanoadaptive responses in normal and neoplastic astrocytes. The data was further validated on patient samples from acidosis driven ischaemia and astrocytic tumour tissues.Results: We demonstrate that low pHe is perceived and interpreted by cells as mechanical stress. GM3 acts as a lipid‐based pH sensor, and in low pHe, its highly protonated state generates plasma membrane deformation stress which activates the IRE1‐sXBP1‐SREBP2‐ACSS2 response axis for cholesterol biosynthesis and surface trafficking. Enhanced surface cholesterol provides mechanical tenacity and prevents acid‐mediated membrane hydrolysis, which would otherwise result in cell leakage and death.Conclusions: In summary, activating these lipids or the associated downstream machinery in acidosis‐related neurodegeneration may prevent disease progression, while specifically suppressing this key mechanical ‘sense‐respond’ axis should effectively target astrocytic tumour growth.


  • Open Access

    Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics

    by Aswani P. Krishna, Sebastian John, Puja Laxmanrao Shinde, Rashmi Mishra

    Background: Glioblastoma multiforme (GBM) is a deadly brain tumour with minimal survival rates due to the ever-expanding heterogeneity, chemo and radioresistance. Kinases are known to crucially drive GBM pathology; however, a rationale therapeutic combination that can simultaneously inhibit multiple kinases has not yet emerged successfully. Results: Here, we analyzed the GBM patient data from several publicly available repositories and deduced hub GBM kinases, most of which were identified to be SUMOylated by SUMO2/3 isoforms. Not only the hub kinases but a significant proportion of GBM upregulated genes involved in proliferation, metastasis, invasion, epithelial-mesenchymal transition, stemness, DNA repair, stromal and macrophages maintenance were also identified to be the targets of SUMO2 isoform. Correlatively, high expression of SUMO2 isoform was found to be significantly associated with poor patient survival. Conclusions: Although many natural products and drugs are evidenced to target general SUMOylation, however, our meta-analysis strongly calls for the need to design SUMO2/3 or even better SUMO2 specific inhibitors and also explore the SUMO2 transcription inhibitors for universally potential, physiologically non-toxic anti-GBM drug therapy. Graphical


  • Open Access

    Extracellular Proton Concentrations Impacts LN229 Glioblastoma Tumor Cell Fate via Differential Modulation of Surface Lipids

    by Sebastian John, K. C. Sivakumar, Rashmi Mishra

    Background: Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer with marginal survival rates. GBM extracellular acidosis can profoundly impact its cell fate heterogeneities and progression. However, the molecules and mechanisms that enable GBM tumor cells acid adaptation and consequent cell-fate competencies are weakly understood. Since extracellular proton concentrations (pHe) directly intercept the tumor cell plasma membrane, surface lipids must play a crucial role in pHe dependent tumor cell-fate dynamics. Hence, a more detailed insight into the finely-tuned pH dependent modulation of surface lipids is required to generate strategies that can inhibit or surpass tumor cell acid adaptation, thereby forcing the eradication of heterogeneous oncogenic niches, without affecting the normal cells. Results: By using image based single cell analysis and physicochemical techniques, we made a small scale survey of the effects of pH ranges (physiological: pHe 7.4, low: 6.2 and very low: 3.4) on LN229 glioblastoma cell line surface remodelling and analyzed the consequent cell fate heterogeneities with relevant molecular targets and behavioural assays. Through this basic study, we uncovered that the extracellular proton concentration 1) modulates surface cholesterol-driven cell-fate dynamics and 2) induces 'differential clustering' of surface resident GM3 glycosphingolipid which together co-ordinates the proliferation, migration, survival and death reprogramming via distinct effects on the tumor cell biomechanical homeostasis. A novel synergy of anti-GM3 antibody and cyclophilin A inhibitor was found to mimic the very low pHe mediated GM3 supra-clustered conformation that elevated the surface rigidity and mechano-remodelled the tumor cell into a differentiated phenotype which eventually succumbed to the anoikis type of cell death, thereby eradicating the tumorigenic niches. Conclusions and Significance: This work presents an initial insight into the physicochemical capacities of extracellular protons in the generation of glioblastoma tumor cell heterogeneities and cell death via the crucial interplay of surface lipids and their conformational changes. Hence, monitoring of proton-cholesterol-GM3 correlations in vivo through diagnostic imaging and in vitro in clinical samples may assist better tumor staging and prognosis. The emerged insights have further led to the translation of a 'pH-dependent mechanisms of oncogenesis control' into the surface targeted anti-GBM therapeutics.


  • Open Access

    Bacoside A Induces Tumor Cell Death in Human Glioblastoma Cell Lines through Catastrophic Macropinocytosis

    by Sebastian John, K C Sivakumar, Rashmi Mishra

    Glioblastoma multiforme (GBM) is a highly aggressive type of brain tumor with an extremely poor prognosis. Recent evidences have shown that the 'biomechanical imbalances' induced in GBM patient-derived glioblastoma cells and in vivo via the administration of synthetic small molecules, may effectively inhibit disease progression and prolong survival of GBM animal models. This novel concept associated with de novo anti-GBM drug development has however suffered obstacles in adequate clinical utility due to the appearance of unrelated toxicity in the prolonged therapeutic windows. Here, we took a 'drug repurposing approach' to trigger similar physico-chemical disturbances in the GBM tumor cells, wherein, the candidate therapeutic agent has been previously well established for its neuro-protective roles, safety, efficacy, prolonged tolerance and excellent brain bioavailability in human subjects and mouse models. In this study, we show that the extracts of an Indian traditional medicinal plant Bacopa monnieri and its bioactive component Bacoside A can generate dosage associated tumor specific disturbances in the hydrostatic pressure balance of the cell via a mechanism involving excessive phosphorylation of CaMK2A enzyme that is further involved in the release of calcium from the smooth endoplasmic reticular networks. High intracellular calcium stimulated massive macropinocytotic extracellular fluid intake causing cell hypertrophy in the initial stages, excessive macropinosome enlargement and fluid accumulation associated organellar congestion, cell swelling, cell rounding and membrane rupture of glioblastoma cells; with all these events culminating into a non-apoptotic, physical non-homeostasis associated glioblastoma tumor cell death. These results identify glioblastoma tumor cells to be a specific target of the tested herbal medicine and therefore can be exploited as a safe anti-GBM therapeutic.


  • Open Access

    mRNA Transcriptomics of Galectins Unveils Heterogeneous Organization in Mouse and Human Brain

    by Sebastian John, Rashmi Mishra

    Background: Galectins, a family of non-classically secreted, β-galactoside binding proteins is involved in several brain disorders; however no systematic knowledge on the normal neuroanatomical distribution and functions of galectins exits. Hence, the major purpose of this study was to understand spatial distribution and predict functions of galectins in brain and also compare the degree of conservation vs. divergence between mouse and human species. The latter objective was required to determine the relevance and appropriateness of studying galectins in mouse brain which may ultimately enable us to extrapolate the findings to human brain physiology and pathologies. Results: In order to fill this crucial gap in our understanding of brain galectins, we analyzed the in situ hybridization (ISH) and microarray data of adult mouse and human brain respectively, from the Allen Brain Atlas, to resolve each galectin-subtype’s spatial distribution across brain distinct cytoarchitecture. Next, transcription factors (TFs) that may regulate galectins were identified using TRANSFAC software and the list obtained was further curated to sort TFs on their confirmed transcript expression in the adult brain. Galectin-TF cluster analysis, gene-ontology annotations and co-expression networks were then extrapolated to predict distinct functional relevance of each galectin in the neuronal processes. Data shows that galectins have highly heterogeneous expression within and across brain sub-structures and are predicted to be the crucial targets of brain enriched TFs. Lgals9 had maximal spatial distribution across mouse brain with inferred predominant roles in neurogenesis while LGALS1 was ubiquitously expressed in human. Limbic region associated with learning, memory and emotions and substantia nigra associated with motor movements showed strikingly high expression of LGALS1 and LGALS8 in human vs. mouse brain. The overall expression profile of galectin-8 was most preserved across both these species, however, galectin-9 showed maximal preservation only in the cerebral cortex. Conclusions: It is for the first time that a comprehensive description of galectins’ mRNA expression profile in brain is presented. Results suggests that spatial transcriptome changes in galectins may contribute to differential brain functions and evolution across species that highlights galectins as novel signatures of brain heterogeneity and functions, which if disturbed, can promote several brain disorders.